Z-0481-2022Class I
ImmunoPass , COVID-19 Neutralizing Antibody Test, NAB 900-60
Empowered Diagnostics LLC / initiated 2021-12-22 / Completed
Empowered Diagnostics LLC began a recall of ImmunoPass , COVID-19 Neutralizing Antibody Test, NAB 900-60 on . FDA classified it as Class I and gives the reason as "COVID test kits were offered for sale and distributed to consumers in the United States without marketing approval, clearance, or authorization from FDA". As of , the recall status on record is Completed.
Recall record
- Recall number
- Z-0481-2022
- Classification
- Class I
- Status
- Completed
- Initiated
- Posted
- Recalling firm
- Empowered Diagnostics LLC
- Product
- ImmunoPass , COVID-19 Neutralizing Antibody Test, NAB 900-60
- Product code
- QKO Reagent, Coronavirus Serological
- Reason for recall
- COVID test kits were offered for sale and distributed to consumers in the United States without marketing approval, clearance, or authorization from FDA.
- FDA root cause
- No Marketing Application
- Action
- The firm notified their direct consignees by letter delivered by email on December 22, 2021. The letter explained the hazard and requested the discontinuation of use and distribution. Those who has further distributed the products, were requested to conduct a sub-recall.
- Quantity in commerce
- 2100 units
- Distribution
- US Nationwide Distribution
- Product codes and lots
- all lots
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0480-2022 | Class I | Completed | Voluntary: Firm initiated | ||
| Z-0481-2022 | Class I | Completed | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
